Elsevier

Annals of Oncology

Volume 29, Supplement 8, October 2018, Page viii372
Annals of Oncology

Abstracts
Head and neck cancer, excluding thyroid
1045O - A phase II window of opportunity study of preoperative olaparib (O) with cisplatin (C) or durvalumab (D) or olaparib alone in in patients with operable squamous cell head and neck carcinoma (HNSCC) (OPHELIA)

https://doi.org/10.1093/annonc/mdy287.001Get rights and content
Under an Elsevier user license
open archive

Cited by (0)